Clinical Trial Update: Role of Serum Regucalcin in Diagnosis of Hepatocellular Carcinoma

View source ↗

Summary

This entry reports a clinical trial investigating serum regucalcin as a diagnostic biomarker for hepatocellular carcinoma, sponsored by Mansoura University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Mansoura University | Conditions: Role of Serum Regucalcin in Diagnosis of HCC | Status: UNKNOWN